|
|
Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
The invention relates to adult dedifferentiated programmable stem cells derived from human monocytes, as well as their production and use for the production of body ...
|
|
|
Peptides which enhance transport across tissues and methods of identifying and using the same
The invention provides a method of identifying a peptide which permits or facilitates the transport of an active agent through a human or animal tissue. A predetermined ...
|
|
|
Synthetic peptides and kits for diagnosis of anti-phospholipid syndrome
The invention claimed is: 1. A synthetic peptide selected from the group consisting: (i) a peptide of SEQ ID NO:1 to SEQ ID NO: 7, of the sequences: Leu-Lys-Thr-Pro-Arg-V...
|
|
|
Synthetic peptide inhibitors of HIV transmission
OF THE INVENTION 5.1 DP-178 AND DP-178-LIKE PEPTIDES 5.2 ASSAYS FOR ANTIVIRAL ACTIVITY 5.3 USES OF THE PEPTIDES OF THE INVENTION 6. EXAMPLE: DP-178 (SEQ ID:1) IS A POTEN...
|
|
|
Compounds which inhibit HIV replication
A first aspect of the present invention is a peptide selected from the group consisting of: (a) the peptide DP-107, which has the formula, from amino terminus to carboxy ...
|
|
|
Hybrid polypeptides with enhanced pharmacokinetic properties
OF THE INVENTION Described herein are peptide sequences, referred to as enhancer peptide sequences, derived from various retroviral envelope (gp41) protein sequences ...
|
|
|
1-aryl-2-hydroxyethyl amides as potassium channel openers
OF THE INVENTION The present invention provides novel aryl hydroxyethyl amides and related derivatives which are modulators of the KCNQ potassium channels and which ...
|
|
|
Method of eliciting anti-HIV-1 helper T cell responses
A number of HIV-1 p24 peptides that elicit HIV-1-specific helper T cell responses have been identified. Contemplated within the scope of this invention are methods of ...
|
|
|
pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
OF THE INVENTION Before the present methods and treatment methodology are described, it is to be understood that this invention is not limited to particular methods, ...
|
|
|
GPIb.alpha. fragments and recombinant DNA expression vectors
As set forth in aforementioned application Ser. No. 07/470,674, there are provided peptides comprising any peptide of the 45 kDa amino terminal tryptic fragment of ...
|